436 related articles for article (PubMed ID: 17406581)
1. Establishment of human tumor xenografts in immunodeficient mice.
Morton CL; Houghton PJ
Nat Protoc; 2007; 2(2):247-50. PubMed ID: 17406581
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of in vivo human tumor models in the NOD/SCID/gamma(c)(null) mouse.
Fujii E; Suzuki M; Matsubara K; Watanabe M; Chen YJ; Adachi K; Ohnishi Y; Tanigawa M; Tsuchiya M; Tamaoki N
Pathol Int; 2008 Sep; 58(9):559-67. PubMed ID: 18801070
[TBL] [Abstract][Full Text] [Related]
3. Establishment of subrenal capsule xenografts of primary human ovarian tumors in SCID mice: potential models.
Lee CH; Xue H; Sutcliffe M; Gout PW; Huntsman DG; Miller DM; Gilks CB; Wang YZ
Gynecol Oncol; 2005 Jan; 96(1):48-55. PubMed ID: 15589579
[TBL] [Abstract][Full Text] [Related]
4. Establishment and characterization of human urothelial cancer xenografts in severe combined immunodeficient mice.
Abe T; Tada M; Shinohara N; Okada F; Itoh T; Hamada J; Harabayashi T; Chen Q; Moriuchi T; Nonomura K
Int J Urol; 2006 Jan; 13(1):47-57. PubMed ID: 16448432
[TBL] [Abstract][Full Text] [Related]
5. Establishment in severe combined immunodeficiency mice of subrenal capsule xenografts and transplantable tumor lines from a variety of primary human lung cancers: potential models for studying tumor progression-related changes.
Cutz JC; Guan J; Bayani J; Yoshimoto M; Xue H; Sutcliffe M; English J; Flint J; LeRiche J; Yee J; Squire JA; Gout PW; Lam S; Wang YZ
Clin Cancer Res; 2006 Jul; 12(13):4043-54. PubMed ID: 16818704
[TBL] [Abstract][Full Text] [Related]
6. Characterization of human ovarian carcinomas in a SCID mouse model.
Xu Y; Silver DF; Yang NP; Oflazoglu E; Hempling RE; Piver MS; Repasky EA
Gynecol Oncol; 1999 Feb; 72(2):161-70. PubMed ID: 10021295
[TBL] [Abstract][Full Text] [Related]
7. A novel method of generating prostate cancer metastases from orthotopic implants.
Corey E; Quinn JE; Vessella RL
Prostate; 2003 Jul; 56(2):110-4. PubMed ID: 12746835
[TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer patient-derived xenografted tumors maintain characteristic features of the original tumors.
Cho YB; Hong HK; Choi YL; Oh E; Joo KM; Jin J; Nam DH; Ko YH; Lee WY
J Surg Res; 2014 Apr; 187(2):502-9. PubMed ID: 24332554
[TBL] [Abstract][Full Text] [Related]
9. Creation and characterization of a xenograft model for human cervical cancer.
Hoffmann C; Bachran C; Stanke J; Elezkurtaj S; Kaufmann AM; Fuchs H; Loddenkemper C; Schneider A; Cichon G
Gynecol Oncol; 2010 Jul; 118(1):76-80. PubMed ID: 20441999
[TBL] [Abstract][Full Text] [Related]
10. Diversity of human leukemia xenograft mouse models: implications for disease biology.
Meyer LH; Debatin KM
Cancer Res; 2011 Dec; 71(23):7141-4. PubMed ID: 22088964
[TBL] [Abstract][Full Text] [Related]
11. Human renal cell carcinoma xenografts in SCID mice: tumorigenicity correlates with a poor clinical prognosis.
Angevin E; Glukhova L; Pavon C; Chassevent A; Terrier-Lacombe MJ; Goguel AF; Bougaran J; Ardouin P; Court BH; Perrin JL; Vallancien G; Triebel F; Escudier B
Lab Invest; 1999 Jul; 79(7):879-88. PubMed ID: 10418828
[TBL] [Abstract][Full Text] [Related]
12. New models for cancer research: human cancer stem cell xenografts.
Baiocchi M; Biffoni M; Ricci-Vitiani L; Pilozzi E; De Maria R
Curr Opin Pharmacol; 2010 Aug; 10(4):380-4. PubMed ID: 20561817
[TBL] [Abstract][Full Text] [Related]
13. Human colorectal tumor xenografts in nude mice: expression of malignancy.
Sordat B; Wang WR
Behring Inst Mitt; 1984 May; (74):291-300. PubMed ID: 6477358
[TBL] [Abstract][Full Text] [Related]
14. On the development of models in mice of advanced visceral metastatic disease for anti-cancer drug testing.
Man S; Munoz R; Kerbel RS
Cancer Metastasis Rev; 2007 Dec; 26(3-4):737-47. PubMed ID: 17846863
[TBL] [Abstract][Full Text] [Related]
15. Growth of benign and malignant schwannoma xenografts in severe combined immunodeficiency mice.
Chang LS; Jacob A; Lorenz M; Rock J; Akhmametyeva EM; Mihai G; Schmalbrock P; Chaudhury AR; Lopez R; Yamate J; John MR; Wickert H; Neff BA; Dodson E; Welling DB
Laryngoscope; 2006 Nov; 116(11):2018-26. PubMed ID: 17075413
[TBL] [Abstract][Full Text] [Related]
16. Tumour growth inhibition of human pancreatic cancer xenografts in SCID mice by cimetidine.
Sürücü O; Middeke M; Höschele I; Kalder J; Hennig S; Dietz C; Celik I
Inflamm Res; 2004 Mar; 53 Suppl 1():S39-40. PubMed ID: 15054609
[No Abstract] [Full Text] [Related]
17. In vivo opossum xenograft model for cancer research.
Wang Z; Hubbard GB; Pathak S; VandeBerg JL
Cancer Res; 2003 Oct; 63(19):6121-4. PubMed ID: 14559788
[TBL] [Abstract][Full Text] [Related]
18. A novel nonobese diabetic/severe combined immunodeficient xenograft model for chronic lymphocytic leukemia reflects important clinical characteristics of the disease.
Dürig J; Ebeling P; Grabellus F; Sorg UR; Möllmann M; Schütt P; Göthert J; Sellmann L; Seeber S; Flasshove M; Dührsen U; Moritz T
Cancer Res; 2007 Sep; 67(18):8653-61. PubMed ID: 17875705
[TBL] [Abstract][Full Text] [Related]
19. The relevance of animal tumour models to the preclinical screening of cytokines.
Kelly SA; Malik ST; Balkwill FR
Cancer Surv; 1989; 8(4):741-54. PubMed ID: 2484311
[TBL] [Abstract][Full Text] [Related]
20. Modelling human leukemia and lymphoma in severe combined immunodeficient (SCID) mice: practical applications.
Flavell DJ
Hematol Oncol; 1996 Jun; 14(2):67-82. PubMed ID: 8876636
[No Abstract] [Full Text] [Related]
[Next] [New Search]
